By Topic

Comparison of quantum-dots- and fluoresceinisothiocyanate- based technology for detecting prostate-specific antigen expression in human prostate cancer

Sign In

Cookies must be enabled to login.After enabling cookies , please use refresh or reload or ctrl+f5 on the browser for the login options.

Formats Non-Member Member
$31 $31
Learn how you can qualify for the best price for this item!
Become an IEEE Member or Subscribe to
IEEE Xplore for exclusive pricing!
close button

puzzle piece

IEEE membership options for an individual and IEEE Xplore subscriptions for an organization offer the most affordable access to essential journal articles, conference papers, standards, eBooks, and eLearning courses.

Learn more about:

IEEE membership

IEEE Xplore subscriptions

7 Author(s)
Ruan, Y. ; Dept. of Urology, Renmin Hosp. of Wuhan Univ., Hubei Province, China ; Yu, W. ; Cheng, F. ; Zhang, X.
more authors

Quantum dots (QDs) are a new class of fluorescent labelling for biological and biomedical applications. In this study, the authors evaluated the sensitivity and stability of quantum-dots-based immunolabelling, in comparison with the conventional fluorescein-isothiocyanate-based immunolabelling (FITC), for detecting prostate-specific antigen (PSA) expression in human prostate cancer. The authors' data revealed that the two methods had similar sensitivity in differential display of the PSA expression correlated with tumour stage and grade (K = 0.88, p<; 0.001). Moreover, the intensity of QDs fluorescence remain stable for 10 days after conjugation to the PSA protein in 97<; of the cases and more than 1 month in 92% of the cases, although the FITC fluorescence became undetectable after 6<;min for all cases.

Published in:

Nanobiotechnology, IET  (Volume:5 ,  Issue: 2 )